Atlas Trials

Aripiprazole Open-Label, Safety and Tolerability Study

Clinical trial NCT00102518 · COMPLETED

Trial details

NCT number
NCT00102518
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SchizophreniaBipolar Disorder
Start date
2004-09-01
Primary completion
2007-02-01
Enrollment
325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.